Search Within

Neeta Pandit-Taskar

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (51)
  2. Meeting Abstract (50)
  3. Book Section (2)
Groups
  1. GSK Faculty (103)
  2. Molecular Imaging and Therapy Service (103)
  3. Molecular Pharmacology and Chemistry Program Faculty (103)
  4. Radiology, Department of (103)
  5. Sloan Kettering Institute Faculty (103)
  6. Medical Physics (62)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (53)
  3. Pat Zanzonico (35)
  4. Serge Lyashchenko (35)
  5. Michael Morris (30)
  6. Howard Scher (29)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (7)
  4. 2021 (3)
  5. 2020 (1)
  6. 2019 (8)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Journal of Nuclear Medicine (21)
  3. Neuro-Oncology (9)
  4. Pediatric Blood and Cancer (8)
  5. Clinical Cancer Research (7)
  6. European Journal of Nuclear Medicine and Molecular Imaging (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Society of Nuclear Medicine (21)
  3. Springer (14)
  4. American Association for Cancer Research (10)
  5. Oxford University Press (9)
  6. Wiley Periodicals, Inc (8)

More Publishers

Results (103)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radjoimmunotherapy (RIT) of central nervous system (CNS) and leptomeningeal (LM) cancers: Phase I study of intra-Ommaya I-131-8H9
    Meeting Abstract

    Kramer, K.; Smith-Jones, P.; Humm, J.; Zanzonico, P.; Pandit-Taskar, N.; Modak, S.; Gerald, W.; Dunkel, I.; Khakoo, Y.; Souweidane, M.; more...
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Effective intrathecal radioimmunotherapy-based salvage regimen for metastatic CNS neuroblastoma (NB)
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Smith-Jones, P.; Zanzonico, P.; Humm, J.; Wolden, S.; Souweidane, M.; Larson, S.; more...
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003
    Journal Article

    Smith-Jones, P. M.; Pandit-Taskar, N.; Cao, W.; O'Donoghue, J.; Philips, M. D.; Carrasquillo, J.; Konner, J. A.; Old, L. J.; Larson, S. M.
    Nuclear Medicine and Biology (2008)

    Fulltext@MSK | Save
  • Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: Lesion detectability and dosimetric projections for 90Y radioimmunotherapy
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Morris, M. J.; Wills, E. A.; Schwartz, L. H.; Gonen, M.; Scher, H. I.; Larson, S. M.; Divgi, C. R.
    Journal of Nuclear Medicine (2008)

    Fulltext@MSK | Save
  • Transient sialoadenitis: A complication of 131I- metaiodobenzylguanidine therapy
    Journal Article

    Modak, S.; Pandit-Taskar, N.; Kushner, B. H.; Kramer, K.; Smith-Jones, P.; Larson, S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2008)

    Fulltext@MSK | Save
  • Phase I study of docetaxel and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Amodio, A. J.; Gignac, G. A.; Flatts, E.; Slovin, S.; Solit, D.; Rathkopf, D.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (Ac-225)-HuM195 (Anti-CD33) in acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S.; Frattini, M. G.; Larson, S. M.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Divgi, C. R.; Bender, S.; O'Donoghue, J. A.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Slovin, S.; Finn, R.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ((124)I-cG250) and PET in patients with renal masses: a phase I trial
    Journal Article

    Divgi, C. R.; Pandit-Taskar, N.; Jungbluth, A. A.; Reuter, V. E.; Gonen, M.; Ruan, S.; Pierre, C.; Nagel, A.; Pryma, D. A.; Humm, J.; more...
    Lancet Oncology (2007)

    Fulltext@MSK | Save
  • Alpha-particle immunotherapy for acute myeloid leukemia (AML) with bismuth-213 and actinium-225
    Meeting Abstract

    Jurcic, J. G.; McDevitt, M. R.; Pandit-Taskar, N.; Divgi, C. R.; Finn, R. D.; Sgouros, G.; Apostalidis, C.; Chanel, S.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save